Sansrosa looks to be marketed as Mirvaso


Thanks to a post from Barbara, we have learnt that a member of a German support forum for rosacea, that Galderma may be planning to market Sansrosa as Mirvaso.

It is pretty brief but here is what we know so far.

Re: New form of therapy!

by Mary »Wednesday 27 July 2013, 08:56

Hello, I once wrote an e-mail to the company Galderma. The gel is under the name ” Mirvaso “(R) and most probably come out in the first quarter of 2014

A press release in German from January 2013 from a dermatologist in Munich appears to confirm this naming as well.


Datum: 15.01.2013 18:49
Kategorie: Gesundheit & Medizin
Pressemitteilung von: Dr. Hans-Ulrich Voigt / Dermatologe am Dom München
PR-Agentur: Peter Sechehaye PR

[Edited Google translation] In the first stage, an IPL or laser therapy, dilated capillaries and the reduction or eliminate more blood flow to the skin. A strong permanent flushing processing or attacks of redness (flushing) may since with the latest Alpha-blockers Brimonidine (Mirvaso cream) effectively treated (for 12 hours).

Galderma does indeed hold the trademark for the name Mirvaso, which has been designated as a dermatological product.

Galderma holds many trademarks so the marketing name for Sansrosa will be confirmed closer to the launch of the product.

More Trial Comments

For the latest comments about the trials for Sansrosa and its sister drug Oxymetazoline see Sansrosa and Afrin Updates from Dr. Fowler & Dr. Webster


The information from Barbara was correct, the product formerly known as Sansrosa has been approved by the FDA under the product name Mirvaso.

Related Articles

About the Author

About the Author: David Pascoe started the Rosacea Support Group in October 1998. .

Follow Rosacea Support

Subscribe via RSS Feed

Leave your comment here


Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.